The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicines that include Ozempic, was cleared to treat moderate to severe OSA in… read on > read on >
An outbreak of salmonella linked to cucumbers has now been tied to 100 known cases of the illness across 23 states, the U.S. Food and Drug Administration reported Thursday. That’s up from 68 cases reported in the FDA’s last tally in early December. Many of the illnesses are severe. “Of the 90 people for whom… read on > read on >
FRIDAY, Dec. 20, 2024 Holy chip! Frito-Lay has issued a limited recall of select 13-oz bags of Lay’s Classic Potato Chips due to the potential presence of undeclared milk, which could pose a serious health risk to individuals with a milk allergy. According to a report released by the U.S. Food and Drug Administration (FDA),… read on > read on >
An existing drug might be able to treat an autoimmune disorder that causes dry eye, dry mouth, fatigue and muscle or joint pain. Baricitinib (Olumiant), a drug currently used to treat rheumatoid arthritis, appears to effectively curb the symptoms of Sjögren’s disease, according to results from lab mice published in a new study. The drug… read on > read on >
THURSDAY, Dec. 19, 2024 (HeathDay News) — The U.S. Food and Drug Administration wants to redefine the meaning of healthy food, issuing a new rule Thursday that changes the way food companies can claim their products are indeed nutritious. What foods will qualify for the new designation? Under the final rule, pretty much everything in the… read on > read on >
The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA first announced two months ago that any shortage of the medications observed during… read on > read on >
.jpg)
The U.S. Department of Justice (DOJ) has filed a civil complaint against CVS Pharmacy Inc., accusing the nation’s largest pharmacy chain of unlawfully filling prescriptions for highly addictive opioids and violating federal health care laws. According to a news release published Dec. 18, 2024, the complaint also accuses CVS of seeking reimbursement for these prescriptions… read on > read on >
Adding cereal to a baby’s bottle is a habit that’s been around for a long time to help introduce solid foods while also supplementing a mom’s breast milk. But this practice can cause babies to pack on some pounds early in life, however, a new study says. Infants were about 50% more likely to experience… read on > read on >
The U.S. Food and Drug Administration (FDA) has issued its most serious warning — a black-box warning — for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but potentially severe liver risks. In new communication issued Dec. 17, the FDA advised that women taking Veozah should undergo regular blood… read on > read on >
A little wine every day can protect your heart health, a new study suggests. People who drank half to one glass of wine a day had a 50% lower risk of heart attack, stroke or heart disease, compared to wine teetotalers, researchers reported Dec. 18 in the European Heart Journal. Even light drinking — one… read on > read on >
